首页 > 市场调查报告书 > 医疗设备

体外诊断

快速医疗诊断试剂盒市场规模、份额和成长分析（按产品、技术、应用、最终用途和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1897965

快速医疗诊断试剂盒市场规模、份额和成长分析（按产品、技术、应用、最终用途和地区划分）—产业预测（2026-2033 年）

Rapid Medical Diagnostic Kits Market Size, Share, and Growth Analysis, By Product (Over the Counter (OTC) Kits, Professional Kits), By Technology (Lateral Flow, Agglutination), By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，快速医疗诊断试剂盒市场规模将达到 172.4 亿美元，到 2025 年将达到 178.2 亿美元，到 2033 年将达到 232.9 亿美元，预测期（2026-2033 年）的复合年增长率为 3.4%。

由于包括呼吸道感染疾病在内的感染疾病率不断上升，全球快速医疗诊断试剂盒市场正经历强劲成长。这些试剂盒在感染疾病的大规模检测和快速识别中发挥关键作用，有助于有效控制疾病，因此市场需求激增。技术进步进一步提升了这些诊断工具的效能，提高了其准确性、灵敏度和易用性，这在资源匮乏地区和医疗照护现场尤其重要。然而，该市场也面临着许多挑战，例如严格的监管要求和品管问题，这些挑战必须克服才能确保结果的可靠性。此外，企业也面临日益激烈的竞争，需要持续投资于研发，以实现创新并满足不断变化的医疗需求。

快速医疗诊断试剂盒市场驱动因素

包括新冠肺炎、流感、爱滋病和各种性行为感染传染病在内的感染疾病日益流行，推动了对快速医疗诊断试剂盒的需求。这些试剂盒能够快速且准确地检测病原体，从而实现疾病的早期识别和适当治疗。这种需求的激增反映了人们对能够提供即时结果的高效医疗解决方案的迫切需求，这对于控制疫情爆发和保障病人安全至关重要。随着医疗系统将快速诊断置于优先地位，这些试剂盒的市场持续扩大，凸显了它们在现代医疗实践和疾病管理中的重要性。

快速医疗诊断试剂盒市场限制因素

快速医疗诊断试剂盒市场面临许多限制因素，其中最主要的限制因素是严格的监管标准，这些标准对于确保产品的安全性、准确性和可靠性至关重要。获得必要的监管核准并确保持续合规的过程耗时耗力，成本高昂。这为市场准入设置了巨大的障碍，尤其对于那些可能缺乏资源来应对这些复杂要求的小型製造商而言更是如此。因此，这可能会阻碍市场成长潜力，限制行业内的创新和竞争，并最终影响消费者获得多样化诊断解决方案的机会。

快速医疗诊断试剂盒市场趋势

快速医疗诊断试剂盒市场正经历着向便携式、易用型设备的显着转变，这主要得益于对高效就地检验的需求，尤其是在偏远、资源匮乏的地区。这一趋势凸显了直觉设计和清晰说明的重要性，使这些设备能够被医疗专业人员和消费者轻鬆使用。远端医疗和居家医疗保健的兴起进一步推动了这一需求，因为易于使用的诊断试剂盒使用户只需接受极少的培训即可进行检测。因此，设计和功能方面的创新对于改善患者预后和促进即时决策至关重要。

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- 雅培实验室（美国）
- ACON 实验室公司（美国）
- Alfa Scientific Designs Inc.（美国）
- Artron Laboratories Inc.（加拿大）
- F. Hoffmann-La Roche Ltd.（瑞士）
- 贝克顿·迪金森公司（美国）
- 生物梅里埃公司（法国）
- BTNX 公司（加拿大）
- Creative Diagnostics（美国）
- 丹纳赫公司（美国）
- 西门子医疗有限公司（德国）
- Bio-Rad Laboratories Inc.（美国）
- 康德乐（美国）
- Meridian Bioscience Inc.（美国）
- Zoetis Inc.（美国）
- 麦克森医疗外科公司（美国）
- Trinity BIoTech（爱尔兰）
- Hologic公司（美国）
- Atlas Link BIoTech Co. Ltd.（中国）
- SD Biosensor Inc.（韩国）

结论与建议

简介目录

Product Code: SQMIG35A2655

Rapid Medical Diagnostic Kits Market size was valued at USD 17.24 Billion in 2024 and is poised to grow from USD 17.82 Billion in 2025 to USD 23.29 Billion by 2033, growing at a CAGR of 3.4% during the forecast period (2026-2033).

The global market for rapid medical diagnostic kits is experiencing robust growth, fueled by the rising incidence of infectious diseases, including respiratory infections. The demand for these kits has surged as they play a pivotal role in mass testing and rapid identification of infections, aiding in effective disease management. Technological advancements have further enhanced the performance of these diagnostic tools, improving accuracy, sensitivity, and usability, which is particularly beneficial in resource-limited environments and point-of-care settings. However, the market faces challenges, including stringent regulatory requirements and quality control issues that must be addressed to ensure reliable results. Companies are also contending with intensified competition, necessitating ongoing investment in research and development to innovate and meet dynamic healthcare demands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Rapid Medical Diagnostic Kits market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Rapid Medical Diagnostic Kits Market Segments Analysis

Global Rapid Medical Diagnostic Kits Market is segmented by product, technology, application, end use and region. Based on product, the market is segmented into over the counter (OTC) kits and professional kits. Based on technology, the market is segmented into lateral flow, agglutination, solid phase and other technologies. Based on application, the market is segmented into blood glucose testing, infectious disease testing, cardiometabolic testing, pregnancy & fertility testing, fecal occult blood testing, coagulation testing, toxicology testing, lipid profile testing and other applications. Based on end use, the market is segmented into hospitals & clinics, home care, diagnostic laboratories and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Rapid Medical Diagnostic Kits Market

The increasing prevalence of infectious diseases, including COVID-19, influenza, HIV, and various sexually transmitted infections, is driving the demand for rapid medical diagnostic kits. These kits offer fast and precise pathogen detection, allowing for timely identification and management of illnesses. This surge in demand is reflective of the need for efficient healthcare solutions that can provide immediate results, which is crucial in controlling outbreaks and ensuring patient safety. As healthcare systems prioritize rapid diagnostics, the market for these kits continues to expand, emphasizing their importance in modern medical practice and disease management.

Restraints in the Rapid Medical Diagnostic Kits Market

The market for rapid medical diagnostic kits faces significant constraints due to the stringent regulatory standards that are essential for guaranteeing safety, accuracy, and reliability. The processes involved in obtaining the necessary regulatory approvals and ensuring ongoing compliance can be both lengthy and costly. This creates substantial barriers to market entry, particularly for smaller manufacturers who may lack the resources to navigate these complex requirements. As a result, the growth potential of the market may be stunted, limiting innovation and competition within the industry, ultimately affecting the availability of varied diagnostic solutions for consumers.

Market Trends of the Rapid Medical Diagnostic Kits Market

The Rapid Medical Diagnostic Kits market is witnessing a notable shift towards portable and user-friendly devices, driven by the need for efficient point-of-care testing, especially in resource-limited and remote settings. This trend emphasizes the importance of intuitive designs and clear instructions, making these devices accessible for both healthcare professionals and consumers. The rise of telemedicine and home healthcare has further accelerated this demand, as easy-to-use diagnostic kits empower users to perform tests with minimal training. As a result, innovation in design and functionality is crucial in enhancing patient outcomes and facilitating quicker decision-making in medical care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Trade Analysis
Customer & Buying Criteria Analysis

Global Rapid Medical Diagnostic Kits Market Size by Product & CAGR (2026-2033)

Market Overview
Over The Counter (OTC) Kits
Professional Kits

Global Rapid Medical Diagnostic Kits Market Size by Technology & CAGR (2026-2033)

Market Overview
Lateral Flow
Agglutination
Solid Phase
Other Technologies

Global Rapid Medical Diagnostic Kits Market Size by Application & CAGR (2026-2033)

Market Overview
Blood Glucose Testing
Infectious Disease Testing
- Covid-19
- Hepatitis
- HIV
- Influenza
- Others
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Lipid Profile Testing
Other Applications

Global Rapid Medical Diagnostic Kits Market Size by End Use & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Home Care
Diagnostic Laboratories
Others

Global Rapid Medical Diagnostic Kits Market Size & CAGR (2026-2033)

North America (Product, Technology, Application, End Use)
- US
- Canada
Europe (Product, Technology, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Scientific Designs Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Artron Laboratories Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTNX Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthcare GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
McKesson Medical-Surgical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atlas Link Biotech Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SD Biosensor Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments